Assessment of Night Vision Problems in Patients with Congenital Stationary Night Blindness by Bijveld, M.M.C. et al.
Assessment of Night Vision Problems in Patients with
Congenital Stationary Night Blindness
Mieke M. C. Bijveld1,2*, Maria M. van Genderen1, Frank P. Hoeben1, Amir A. Katzin1, Ruth M. A. van
Nispen3,4, Frans C. C. Riemslag1,5, Astrid M. L. Kappers2
1 Bartime´us Institute for the Visually Impaired, Zeist, The Netherlands, 2MOVE Research Institute, Faculty of Human Movement Sciences, VU University, Amsterdam, The
Netherlands, 3Department of Ophthalmology, VU University Medical Center, Amsterdam, The Netherlands, 4 EMGO+ Institute for Health and Care Research, VU University
Medical Center, Amsterdam, The Netherlands, 5 The Rotterdam Eye Hospital, Rotterdam, The Netherlands
Abstract
Congenital Stationary Night Blindness (CSNB) is a retinal disorder caused by a signal transmission defect between
photoreceptors and bipolar cells. CSNB can be subdivided in CSNB2 (rod signal transmission reduced) and CSNB1 (rod signal
transmission absent). The present study is the first in which night vision problems are assessed in CSNB patients in
a systematic way, with the purpose of improving rehabilitation for these patients. We assessed the night vision problems of
13 CSNB2 patients and 9 CSNB1 patients by means of a questionnaire on low luminance situations. We furthermore
investigated their dark adapted visual functions by the Goldmann Weekers dark adaptation curve, a dark adapted static
visual field, and a two-dimensional version of the ‘‘Light Lab’’. In the latter test, a digital image of a living room with objects
was projected on a screen. While increasing the luminance of the image, we asked the patients to report on detection and
recognition of objects. The questionnaire showed that the CSNB2 patients hardly experienced any night vision problems,
while all CSNB1 patients experienced some problems although they generally did not describe them as severe. The three
scotopic tests showed minimally to moderately decreased dark adapted visual functions in the CSNB2 patients, with
differences between patients. In contrast, the dark adapted visual functions of the CSNB1 patients were more severely
affected, but showed almost no differences between patients. The results from the ‘‘2D Light Lab’’ showed that all CSNB1
patients were blind at low intensities (equal to starlight), but quickly regained vision at higher intensities (full moonlight).
Just above their dark adapted thresholds both CSNB1 and CSNB2 patients had normal visual fields. From the results we
conclude that night vision problems in CSNB, in contrast to what the name suggests, are not conspicuous and generally not
disabling.
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Introduction
The Schubert-Bornschein type of Congenital Stationary Night
Blindness (CSNB) comprises a genetically heterogeneous group of
stationary retinal disorders, caused by defective signal transmission
between photoreceptors and bipolar cells. Because of this defect,
the standard flash electroretinogram (ERG) is electronegative
(normal a-wave, absent b-wave) [1]. Symptoms associated with
CSNB are high refractive error, decreased visual acuity, nystag-
mus, and abnormal dark adaptation.
CSNB can be subdivided into ‘‘complete’’ CSNB (CSNB1) and
‘‘incomplete’’ CSNB (CSNB2) based on differences in ERG [2].
CSNB2 is caused by defective proteins on the synaptic terminal of
photoreceptors, which are involved in continuous calcium-de-
pendent neurotransmitter release. Therefore, the transmission of
both rod and cone signals is affected but reduced activity remains
present [3]. The ERG in CSNB2 shows reduced but recordable
rod function and reduced cone function. CSNB1 is caused by
abnormal proteins on the ON bipolar cell. Because rod signals
primarily travel through ON bipolar cells, defective ON bipolar
cell function leads to completely absent rod pathway signalling [4]
and the ERG of CSNB1 patients show no residual rod function.
CSNB segregates in X-linked (xl) and autosomal-recessive (ar)
form. To date, four genes are associated with CSNB1: NYX (xl)
[5,6], GRM6 (ar) [7,8], TRPM1 (ar) [9–11], and GPR179 (ar) [12].
Two disease genes have been implicated in CSNB2: CACNA1F (xl)
[13], and CABP4 (ar) [14,15].
The dark adaptation (DA) curve is a diagnostic tool used as
a psychophysical measurement of night blindness [16]. The DA
curve records the adaptation of rods and cones to darkness after
a period of bright light stimulation (usually 5 to 10 min). Rod
signal transmission is impaired in both CSNB2 and CSNB1,
resulting in an abnormal DA curve with an elevated dark adapted
threshold. However, the relationship between the DA curve and
night vision problems is unclear. The DA curve provides no
information on the visual field, while a sufficient visual field is
essential for mobility and orientation. Also, the DA curve does not
predict the visual functioning at light levels above the patient’s
threshold.
Although the condition is named ‘‘night blindness’’, not all
CSNB patients experience night vision problems. We recently
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performed a study on 101 CSNB patients [17]. In this study, all
CSNB1 patients reported night vision problems, in contrast to only
54% (31/57) of the CSNB2 patients. Other studies also reported
symptomatic night blindness in all CSNB1 patients [6,18,19], but
symptoms in CSNB2 varied: night blindness was reported in all
[18,19], in none [20–22] or some CSNB2 patients [13,23–25].
However, the frequency and severity of night vision problems in
CSNB patients have never been investigated thoroughly.
The purpose of this study was to improve rehabilitation of
CSNB patients. Therefore, we assessed night vision problems in
a group of CSNB patients with a questionnaire, to evaluate how
often patients experience night vision problems in various
situations. Furthermore, we assessed the visual functions of CSNB
patients at low light intensities by means of the conventional DA
curve and two other tests: the ‘‘scotopic visual field’’ and the ‘‘2D
Light Lab’’. The scotopic visual field consisted of measurements of
the dark adapted threshold at different locations in the visual field.
In the 2D Light Lab, we projected an image of a living room on
a screen. While slowly increasing the light intensity of the
projection, we asked the patients to report on the detection and
recognition of the objects at different light levels.
Materials and Methods
Ethics Statement
The research followed the tenets of the Declaration of Helsinki.
All participants were minimally 12 years of age, and we obtained
written informed consent from each of the participants, and from
the parents of patients under 18 years of age. Local ethical
approval of the Bartime´us Institute was obtained for this
procedure and this study.
Subjects
Twenty healthy subjects (12 female, 8 male) participated as
control subjects for the scotopic visual field and the 2D Light Lab.
Their age ranged from 12 to 53 years, with an average of 29 years.
All had normal vision and a refractive error between 25.0 D and
+5.0 D, except for one subject who was highly myopic (211D).
His results were comparable to the other normal subjects.
We recruited participants from our previous study on 101
CSNB patients [17]. In this study, the phenotype data included full
ophthalmic examinations and ERG. The patients were diagnosed
with CSNB1 or CSNB2 based on standard ERG measurements.
Subsequently, in 93% of the patients a causative mutation was
found that confirmed the electrophysiologically established di-
agnosis; 7% of the patients had an unknown genetic defect. This
study showed that the diagnostic differentiation of CSNB1 and
CSNB2 can reliably be made on the basis of ERG. From this
cohort, we selected patients on the basis of age and travel distance
from the Bartime´us Institute. Twenty-three of twenty-six invita-
tions were accepted.
Fourteen CSNB2 patients participated in this study. One
CSNB2 patient showed unusual behaviour compared to the other
patients as he walked with a cane and his mesopic visual field
showed abnormalities. (The mesopic visual field is a standard test
that is performed at intensities were both cones and rods are
active.) Because we doubted whether his impaired visual functions
could be attributed to CSNB alone, and because the patient
refused further investigations, we had to remove his results from
the study. The other thirteen CSNB2 patients had a normal or
near normal mesopic visual field. Their average age was 24 years,
their average visual acuity was 0.44 log Mar, and their average
refractive error was 25.5D spherical equivalent. Individual data is
given in Table 1. Subjects 2.6 and 2.10, subjects 2.7 and 2.8 and
subjects 2.13 and 2.9 were brothers. Nine CSNB1 patients
participated in this study. All had a normal or near normal
mesopic visual field. Their age was on average 22 years, their
average visual acuity was 0.23 log Mar, and their average
refractive error was 27.0D spherical equivalent. Subjects 1.7 and
1.8 were brothers.
All 13 CSNB2 patients showed the typical CSNB2 ERG
phenotype: reduced but recordable dark-adapted rod ERG,
electronegative dark-adapted rod-cone ERG, reduced light-
adapted cone ERG. All 9 CSNB1 patients showed the typical
CSNB1 ERG phenotype: none recordable dark-adapted rod
ERG, electronegative dark-adapted rod-cone ERG, close to
normal light-adapted cone ERG. In all CSNB patients the
causative mutation was found, except for one CSNB1 patient (see
Table 1). The 13 CSNB2 patients and the 9 CSNB1 patients
showed comparable variations in visual acuity, refractive error,
and DA curve as the 62 CSNB2 and the 39 CSNB1 patients which
we described in the previous study. Therefore, we assume that our
cohort of patients constitutes a fairly representative group of
CSNB2 and CSNB1 patients.
Questionnaire
We developed a questionnaire based on two low luminance
questionnaires available from the literature. The 35-items ques-
tionnaire of Turano et al. has been validated to monitor the
independent mobility of patients with retinitis pigmentosa (RP)
[26] and patients with glaucoma [27]. The 32-items questionnaire
of Owsley et al. [28,29] has been validated in patients with age-
related maculopathy (ARM) to recognize the first ARM
symptoms. However, RP and ARM are progressive diseases that
affect the visual field, while CSNB is stationary and visual fields are
normal, so not all questions were relevant for our study. Therefore,
we made a selection and also added questions based on our own
lab experience.
The questionnaire existed of seven parts. In Part 1, we asked the
patient about the lighting conditions in his direct living environ-
ment, and the frequency of outdoor activities in summer and
winter. In Part 2, the patient was asked to describe three situations
in which he experienced restrictions or difficulties because of his
vision at night. Part 3 dealt with means of transportation during
the day, in twilight, and in the dark, and the influence of night
vision problems on the choice of transportation. In Part 4 (6 items),
we asked the patient how often he used assistance (a cane, another
person, a flash light etc.) when walking outside in the dark. In the
last three parts, we asked the patient how often he experienced
a certain problem or difficulty in the dark without assistance:
‘‘outdoor problems’’ (Part 5; 12 items), ‘‘indoor problems’’ (Part 6;
6 items), and ‘‘general problems’’ (Part 7; 6 items). Response
options for Part 4–7 were: never, sometimes, regularly, often,
always (scored 1 for ‘‘never’’ up to 5 for ‘‘always’’). The patient
was asked to tick ‘‘not applicable’’ if an activity was never
performed, or only performed with assistance. The complete
questionnaire can be found in the supplemental data (Appendix
S1).
The results from the questionnaire are given as follows: we give
a summarized description of the answers of the first three parts of
the questionnaire. To visualize the distribution of response
categories for separate items of Parts 4–7, we scored how many
of the five possible categories were given per item by CSNB1 and
CSNB2 patients, respectively. We give the first quartile, the
median and the third quartile of the answers per question, i.e. the
25%, 50% and 75% cut off of the ranked data. We excluded
patients who ticked ‘‘not applicable’’, which occurred no more
than twice per question.
Night Vision Problems in CSNB Patients
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Dark Adaptation Curve
We recorded dark adaptation curves (DA curve) with a Gold-
mann-Weekers Dark Adaptometer in a completely darkened room
after the subjects were light-adapted with a Ganzfeld background
(about 1000 cd/m2) for 10 minutes. The binocular threshold was
measured during 20 to 25 minutes of dark adaptation, using an
11o off-central white circular target with a diameter of 56 mm, or
11u. The stimulus was presented at a 0.5 Hz flicker rate. The
manufacturer of Goldmann-Weekers Dark Adaptometer supplies
examples of normal data for various age ranges. The results of our
patients were compared to the standard DA curve of subjects
between 20 and 40 years old.
Scotopic Visual Field
We measured binocular static scotopic visual fields using the
Perimeter Octopus 900 (Haag-Streit AG, Switzerland). We
adapted the perimeter to make it suitable for this purpose. The
subject was positioned in front of the bowl by a head and chin rest.
The central green fixation dot was filtered by a red filter so that
a very dim red fixation dot remained, which was still visible to all
subjects. The measurements were performed in complete dark-
ness. Background light was turned off and black tape suppressed
visible red light from infrared LEDs. We also covered the buttons
and the screen in and outside the Octopus bowl and dimmed the
computer screen with filters to minimize scatter light.
We chose target locations from the Esterman visual field [30],
because it is a very wide visual field test. We removed several
target locations to keep measurement time acceptable (,15 min).
Fig. 1 shows the standard Esterman target locations (grey) and the
36 selected locations (black). To analyse the homogeneity of the
threshold across the visual field, we averaged the thresholds of four
locations at 7u, 45u, 60u and 75u on the horizontal axes (large black
diamonds in Fig. 1).
Table 1. Characteristics of the thirteen CSNB2 and nine CSNB1 patients that participated in the study.
type age [y] gender visual acuity [log Mar]
refractive error
[D]* nystagmus gene mutated
1.1 CSNB1 12 male 0.12 211.1 no NYX
1.2 CSNB1 19 female 0.52 21.9 yes TRPM1
1.3 CSNB1 27 male 0.35 213.3 yes NYX
1.4 CSNB1 37 male 0.52 211.5 yes NYX
1.5 CSNB1 18 male 0.05 24.9 yes unknown
1.6 CSNB1 13 male 0.30 25.6 yes TRPM1
1.7 CSNB1 23 male 0.00 29.0 yes NYX
1.8 CSNB1 27 male 0.22 29.6 yes NYX
1.9 CSNB1 23 male 0.00 25.2 no NYX
2.1 CSNB2 16 male 0.26 23.6 yes CACNA1F
2.2 CSNB2 25 male 0.15 24.3 no CACNA1F
2.3 CSNB2 27 male 0.52 22.9 yes CACNA1F
2.4 CSNB2 31 male 0.20 27.8 no CACNA1F
2.5 CSNB2 19 male 0.30 211.0 yes CACNA1F
2.6 CSNB2 26 male 0.30 25.8 no CACNA1F
2.7 CSNB2 32 male 1.00 29.8 yes CACNA1F
2.8 CSNB2 29 male 0.40 26.0 yes CACNA1F
2.9 CSNB2 14 male 0.30 0.0 no CACNA1F
2.10 CSNB2 20 male 0.22 29.9 yes CACNA1F
2.11 CSNB2 21 male 1.00 23.5 yes CACNA1F
2.12 CSNB2 18 male 0.70 28.9 yes CACNA1F
2.13 CSNB2 16 male 0.40 1.2 no CACNA1F
*Refractive errors are given in spherical equivalent dioptres.
doi:10.1371/journal.pone.0062927.t001
Figure 1. Target locations of the scotopic visual field. The
scotopic visual field locations (black) were based on the locations used
in the Esterman test (black and grey). The large diamonds represent the
locations that were used to determine the homogeneity of the visual
field by comparing the average threshold at 7u, 45u, 60u, and 75u.
doi:10.1371/journal.pone.0062927.g001
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We used the largest size stimulus (64 mm2, Goldmann V) to rule
out visual acuity as a determining factor. We used the dimmest
stimulus (blue, l=440 nm +/225 nm) and minimized the flash
duration to 100 ms. The maximal intensity (0 dB) of the stimulus
was 16 apostilb, i.e. 5.1 cd/m2. The stimulus could be dimmed
47 dB. Because the minimal intensity was still easily detectable by
control subjects and CSNB2 patients, for these subjects we filtered
the stimulus with an extra 3.0 log units of intensity neutral density
filter. In the CNSB1 patients, we measured the scotopic visual field
without the extra filter. In five CSNB1 patients we also completed
a test with the filter. In these five patients, the threshold could be
determined in both tests at 118 target locations. The values
differed on average 28 dB, standard error 0.2 dB. Thus, the
measuring range in control subjects and CSNB2 patients was 28 to
75 dB, while in the CSNB1 patients it was 0 to 47 dB. If the
brightest stimulus (28 dB or 0 dB, respectively) could not be
detected, the measurement of that target location was removed
from the data set.
The measurement of the scotopic visual field started in the
four locations at 7u at an intensity of 52 dB (with filter) or
24 dB (without filter). If the subjects did not respond to the first
stimulus, the intensity was increased in a 6 dB step. Thereafter,
the process continued with brighter spots in steps of 8 dB until
the subject perceived the stimulus and pressed the button for
a ‘‘yes’’. Then, the procedure continued at all locations but in
a random order, in a one-up one-down staircase method with
decreasing step size. The initial stimulus intensity at these
locations started at an intensity higher than that of the
threshold, as determined in the four locations at 7u. The
stimulus intensity subsequently decreased in 4 dB intensity steps
until the subjects no longer perceived the stimulus. We repeated
the procedure in 2 dB steps in the opposite direction, and
finally again in 1 dB steps to determine the threshold with
a nominal accuracy of +/21 dB.
We statistically compared the thresholds found in the control
subjects, the CSNB2 patients, and the CSNB1 patients. We first
averaged the thresholds per subject and then compared the groups
by One Way ANOVA and subsequent Bonferroni corrected Post
Hoc tests for pairwise multiple comparisons.
2D Light Lab
The two dimensional (2D) Light Lab was derived from the
original three dimensional (3D) Light Lab [31] which consists of
a real living room filled with daily objects. In the 3D Light Lab,
patients are asked to describe the objects they detect and
recognize at increasing light levels. The 2D Light Lab consisted
of an image of a living room that was projected on a screen.
The image used in these experiments was constructed from
separate photo’s using photo-editing software (Corell Paintshop
Photo Pro X3), which made it easier to control intensity and
contrast. The image, shown in Fig. 2, contained 22 everyday
objects that varied in size and colour. The distance between
screen (4:3, 2.40 m, Projecta) and projector (Sanyo PLC-
XP100L, 3LCD, XGA) was 4 m. The subject sat on a chair
4 m from the screen, at an angle of 10u from the midline
between projector and screen. Apart from the light from the
screen, the room was completely dark. We used a retro
reflective screen with a directed reflectivity a factor 2.4 larger
than that of a standard white screen, so that the luminance in
the direction of the projector was high, but indirect light
scattering from the walls was minimized.
From the position of the subject, the maximum luminance
measured on the screen was 2.8 log cd/m2. This was measured
on the table-lamp which was the brightest object of the image.
This maximal luminance is comparable to a white object
(reflection factor 0.8) in a room with an illuminance of
2600 lux. We adjusted the luminance of the screen by placing
neutral density (ND) filters in front of the projector. We
combined a 3.0, 2.0 or 1.0 log units ND filter with a 0.5 log
units ND filter. In addition, the subject wore goggles with 3.0
log ND filters during the first part of the experiment, and then
removed the goggles. To prevent condensation of the goggles,
two tubes were placed underneath the goggles and connected to
a small air pump.
At the start of the experiment, the light level was maximally
dimmed by 6.5 log units of intensity. Under these conditions, the
luminance of the brightest object in the 2D Light Lab is
comparable to the luminance of a white paper in starlight, i.e.
23.7 log cd/m2 [32]. We then increased the light level to maximal
intensity in 14 steps of 0.5 log units. At 3.5 log units, the luminance
of the brightest object is comparable to the luminance of a white
paper in full moonlight, i.e. 20.7 log cd/m2 [32].
During the experiment, we asked the subject to describe his
observations. We noted detection (d, see ‘something’, usually
roughly the outline of the object) and recognition of the 22 objects
per intensity step. For each step, the subject had several minutes to
adapt to the light level and to inspect the image thoroughly.
For each intensity, the cumulative number of objects that was
detected or recognized was divided by the total number of objects.
This data plotted against the intensity resembled a logistic
psychometric function:f (i, slope, i50)~ 1
1ze{slope(i{i50)
. Here, i is
the intensity, slope is the slope of the curve, and i50 is the intensity
at which 50% of the objects were detected or recognized. We
assumed that the subjects could detect and recognize all objects at
maximal intensity. We fitted a psychometric function to the light
lab data involving detection (d) and recognition (r) of each subject.
We determined and statistically compared sloped, sloper, i50d, and
i50r between the control subjects, the CSNB2 patients, and the
CSNB1 patients, using a One Way ANOVA test and subsequent
Bonferroni corrected Post Hoc tests for pairwise multiple
comparisons. Finally, we performed simple linear regression
analyses between i50d, i50r, and visual acuity and determined
the Pearson correlation coefficients.
Testing Procedure
For the control subjects, the complete experiment consisted of
the scotopic visual field test and the 2D Light Lab test. Before
the start of the scotopic visual field test, the subject dark
adapted for 20 minutes by wearing occluding goggles. After-
wards, the subject was asked to again put on the occluding
goggles. The examiner then guided the blindfolded subject to
the room with the 2D Light Lab test. Before the start of this
test, the subject replaced the occluding goggles by the 3.0 log
goggles, while keeping his eyes closed. The examiner assisted
under minimal light levels.
The procedure for the patients was more extensive. We asked
the patients to fill in the questionnaire at home. Before starting the
experiments, the examiner shortly discussed the questionnaire with
the patients, to make sure they had answered and correctly
understood all questions. The experiment started with the dark
adaptation curve, which was recorded for 20 to 25 min. Sub-
sequently, the patient was asked to put on the occluding goggles.
The examiner then guided the blindfolded patient to the room
where the scotopic visual field test was performed. Because the
patient was already dark adapted, the experiment could start
immediately. Thereafter, the tests were performed in the same
manner as in the control subjects.
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Results
Questionnaire
In Part 1, both CSNB2 and CSNB1 patients reported going out
almost as often or equally often in winter as in summer time. In
Part 2, we asked the patients to describe three situations in which
they felt restricted or bothered because of their vision at night.
Several CSNB2 patients described mobility problems, for instance
having to walk or cycle without enough streetlight. CSNB1
patients in addition described problems recognizing persons or
finding their seat during social events like going out to the pub,
cinema, or at a campsite.
In Part 3, all CSNB2 and CSNB1 patients reported going out
on foot during the day, at twilight, and at night (if necessary with
a flashlight), except for one young CSNB1 patient who was not
allowed to go out alone at night because of his age. He and one
other CSNB1 patient only cycled during the day, and two CSNB2
patients did not cycle at all (the bicycle is the most frequently used
means of transportation in the Netherlands). All other patients
cycled under all circumstances. Five CSNB2 and three CSNB1
patients had a car driving licence but two of the CSNB2 patients
were only permitted to drive during the day. Only one CSNB1
patient chose to not obtain his driving license because of his vision
at night, although he met the criteria for a driving license during
the day. The other patients had other reasons for not having
a driving license: they were either too young, did not meet the
minimal visual acuity criterion, or preferred other means of
transportation. One CSNB2 patient reported to be a truck driver.
Fig. 3 shows the first quartile, the median and the third quartile
of ranked response options the patients gave to Parts 4 to 7 of the
questionnaire, dealing with assistance or devices, outdoor prob-
lems, indoor problems, and general problems. The results show
that CSNB2 patients answered most questions about problems
with ‘‘never’’ or ‘‘sometimes’’, while CSNB1 patients experienced
problems more frequently. None of the CSNB2 and CSNB1
patients used a cane when walking in the dark (Q10), but CSNB1
patients sometimes used other aids (Q11–13). One CSNB1 patient
described that he sometimes used his phone as a flashlight (Q14),
and one CSNB2 patient described to always seek for the best
illuminated areas (Q15). Both CSNB2 and CSNB1 patients
experienced less problems moving about or finding their way in
a familiar environment (Q17,18) compared to an unfamiliar
environment (Q19,20). None of the CSNB2 patients and only two
of the CSNB1 patients reported going out less often than they
wanted because of their vision at night (Q27). Both CSNB2 and
CSNB1 patients reported more problems in Part 6 (Indoor
problems like recognizing faces or reading a book) compared to
Parts 4, 5 and 7. Finally, CSNB1 patients felt blind at night (Q36),
insecure at a social event (Q37), restricted because of their vision at
night (Q38) and dependent on others in dark circumstances (Q39),
but at different frequencies. CSNB2 patients mostly reported
‘‘never’’ or ‘‘sometimes’’ to these questions.
Dark Adaptation Curve
In normal subjects, the DA curve shows a biphasic form, with
an early cone-mediated phase during the first 5 min and a later
rod-mediated phase (Fig. 4, green solid curve). The dark
adaptation curves of the CSNB2 patients also show such a biphasic
form but the final threshold was elevated, see Fig. 4. The threshold
after 5 min varied between 4.0 and 5.5 log units, a range of 1.5 log
units, and after 25 min between 2.2 and 3.7 log units, a range of
1.5 log units. In contrast, in the CSNB1 patients the variation in
the threshold was large at the beginning of the dark adaptation
curve, but decreased as the dark adaptation continued. The
threshold after 5 min varied between 4.8 and 5.8 log units, a range
of 1 log unit, but the final threshold after 20 min was found
between 4.55 and 4.8 log units, a range of only 0.25 log units.
Compared to the final threshold of 1.8 log units in a control
subject, the final threshold elevation was between 0.4 and 1.9 log
units in the CSNB2 patients and about 3 log units in the CSNB1
patients.
Scotopic Visual field
In Fig. 5A we plotted the thresholds found at the 36 target
locations per subject. Occasionally, the brightest stimulus could
not be detected by the subjects. The measurement of that target
location was removed from the data set. This happened for one
target location in one control subject, in one target location in
a CSNB2 patient, and in two target locations in another CSNB2
Figure 2. The constructed image of a living room used in the 2D Light Lab. The image contained 22 everyday objects that varied in size,
colour and contrast. The objects were (from left to right and top to bottom): small television, alarm clock, table-lamp, armchair, trashcan, cupboard,
bench, coat hanger, vase, plant, playing card, mug, dark table, pencil, white table, telephone, chair, pair of gloves, newspaper, hammer, screwdriver
and watch. The left image (A) shows the image at full intensity, the right image (B) shows the image at a low intensity.
doi:10.1371/journal.pone.0062927.g002
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patient. The average thresholds per control subject (open green
circles) were found between 53 dB and 61 dB, with an average of
57 dB. The CSNB2 patients had an average threshold per subject
(open black diamonds) between 41 dB and 55 dB, with an average
of 48 dB. The CSNB1 patients had an average threshold per
subject (open blue triangles) between 22 dB and 34 dB, with an
average of 28 dB. The One-Way ANOVA test showed significant
differences between the average thresholds found in each group,
F=230.0, p,0.0001. Bonferroni corrected Post Hoc tests showed
that all three groups were significantly different from one another
(for all three pairs, p,0.0001).
We found a small decline of the threshold from 7u to 60u and
a stronger decline between 60u and 75u, see Fig. 5B. For the
control subjects, the average thresholds at 7u, 45u, 60u and 75u
were 62, 59, 58 and 49 dB respectively. In the CSNB2 patients,
these were 52, 50, 49 and 42 dB and in the CSNB1 34, 31, 29 and
19 dB.
2D Light Lab
The 2D Light Lab results of a representative control subject,
a CSNB2 patient, and a CSNB1 patient are given in Fig. 6A. It
shows the cumulative number of objects detected (filled symbols)
and recognized (open symbols), and the fit of the two psychome-
trical curves. The steepness of the two curves of the CSNB2
patients were almost equal to those of the control subjects, but the
curves are shifted toward higher intensities. The two curves of the
CSNB1 patients were also shifted towards higher intensities, and
in addition steeper and closer together compared to control
subjects.
Fig. 6B shows the psychometric curves for detecting objects of
all subjects. As can be seen, the curves for detection of the CSNB1
patients were steeper compared to those of the control subjects and
CSNB2 patients. Furthermore, the position of the curves on the
horizontal axis (i50d) varied but little among CSNB1 patients and
the most among CSNB2 patients. I50d and i50r varied over a range
of 0.5 and 0.5 log units resp. for the CSNB1 patients, and 2.4 and
2.1 log units resp. for the CSNB2 patients.
Fig. 6C shows the values of the steepness of the psychometrical
curves for detection (sloped) and recognition (sloper), and of the
intensities at which 50% of the objects were detected (i50d) and
recognized (i50r). We performed One-Way ANOVA tests and
Bonferroni corrected Post Hoc tests to analyse the differences of
these variables between control subjects, CSNB2, and CSNB1
patients, see Table 2. In the CSNB1 patients, there was one
outlier (sloped = 20.4) that was removed before further analyses.
We found that the steepness of the curves (sloped and sloper) of
the CSNB1 patients differed significantly from those of the
control subjects and CSNB2 patients. Sloped was just significantly
different (p,0.05) and sloper was not significantly different
between the control subjects and CSNB2 patients. The position
of the curves on the horizontal axis (i50d and i50r) were
significantly different between all three groups, except for i50r
which was not significantly different between the CSNB2 and
CSNB1 patients. Finally, we found that the curves for detection
and recognition were significantly closer together in the CSNB1
Figure 3. Results of Parts 4 to 7 of the questionnaire. Top: answers of CSNB2 patients. Bottom: answers of CSNB1 patients. The black horizontal
lines indicate the medians. The grey vertical lines extend from the first quartile to the third quartile and thus indicate the range of the mid 50%
ranked answers. A black dot is used when the mid 50% ranked date contained one answer only.
doi:10.1371/journal.pone.0062927.g003
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patients compared to the control subjects and the CSNB2
patients (see Tabel 2, i50r–i50d).
The objects that were first detected and recognized were the
larger objects and the objects with a high contrast with the
environment: the table-lamp, the armchair, the cupboard, and the
dark and white table. But in fact, the screen itself was the first
object to be detected. Remarkably, although not systematically
recorded, the CSNB1 patients did not see the screen at all and
therefore did not know where to look until just before the first
objects were detected. The objects that were last detected and
recognized were small and had a low contrast with the
environment: the coat hanger, the pencil, the pair of gloves, the
mug, and the screwdriver.
Fig. 7A shows the linear regression between the intensity at
which 50% of the objects were detected (i50d) and the visual
acuity. The Pearson correlation coefficient was significant for the
CSNB2 patients: R=0.84, p,0.01, but not for the CSNB1
patients: R=0.41, p.0.05. In contrast, we found a significant
Pearson correlation coefficient for both patient groups between the
intensity at which 50% of the objects were recognized (i50r) and
the visual acuity (Fig. 7B). For the CSNB2 patients we found:
R=0.92, p,0.01, and for the CSNB1 patients: R=0.86, p,0.01.
The four CSNB2 patients with the poorest visual acuity needed
the most light to detect and recognize the objects. In contrast, i50d
and i50r found for the CSNB1 patients differed little, while the
patients had variable visual acuities.
Discussion
In this study we assessed night vision problems in 13 CSNB2
patients and 9 CSNB1 patients through a questionnaire, and three
scotopic tests: a DA curve, a scotopic visual field and a 2D Light
Lab. We found several differences between the CSNB2 and the
CSNB1 groups.
The CSNB2 patients answered most questions from the
questionnaire regarding problems with ‘‘never’’ or ‘‘sometimes’’.
They did not recognize the situations described in the ques-
tionnaires as problematic and did not feel blind at night. They
Figure 4. Dark adaptation curves of the CSNB2 patients (A) and
CSNB1 patients (B), and a control subject (green curve). The
normal DA curve shows a biphasic form, with an early cone-mediated
phase and a later rod-mediated phase. The DA curves of the CSNB2
patients also showed such a biphasic form. Their final thresholds were
variably elevated. The DA curves of the CSNB1 patients only showed
a cone-mediated phase. Their final thresholds were all approximately 3
log units elevated.
doi:10.1371/journal.pone.0062927.g004
Figure 5. Scotopic visual field results of the normal subjects, the CSNB2 patients, and the CSNB1 patients. A: The threshold found at
each location of the scotopic visual field, plotted per subject. The open markers represent the average threshold found in that subject. The dashed
lines indicate the measuring range, which was 28 to 75 dB in control subjects and CSNB2 patients, and 0 to 47 dB in CSNB1 patients. We found
slightly elevated thresholds in CSNB2 patients compared to the thresholds of normal subjects. The thresholds were more elevated in the CSNB1
patients. B: The averaged thresholds of four locations at 7u, 45u, 60u and 75u on the horizontal axes per subject. Thresholds were slightly elevated
towards the far end of the visual field in control subjects. We found an equal decline in the control subjects, the CSNB2 and the CSNB1 patients.
doi:10.1371/journal.pone.0062927.g005
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more frequently reported to have difficulties reading a paper or
a book in an insufficiently lighted environment (Q21). Therefore,
in CSNB2 patients poor visual acuity appears to be more disabling
than night blindness.
The scotopic test results of the CSNB2 patients showed
similarities to those of the control subjects, although there were
variations among patients. The dark adaptation curves of the
CSNB2 patients showed a biphasic form, similar to the DA curve
Figure 6. 2D Light Lab results of the normal subjects, the CSNB2 patients, and the CSNB1 patients. A: Three representative examples of
the results from the 2D Light Lab. The figure shows the cumulative of the relative number of objects detected or recognized, the fit of the
psychometric curve, and the crossmarks that indicate the intensity at which 50% of the objects were detected or recognized (i50d and i50r). B: The
psychometric fit to the cumulative of objects detected at increasing light levels in the 2D Light Lab for each subject. The green dots (control subjects),
black diamond (CSNB2 patients) and blue triangles (CSNB1 patients) in each fit indicate i50d and i50r. C: The parameters (slope, left) and (i50, right) of
the psychometric fit to the 2D Light Lab results of all subjects. Overall we found equal slopes for detection and recognition in control subjects and in
CSNB2. However, in the CSNB2 patients the curves were shifted toward higher intensities. The two curves of the CSNB1 patients were steeper, closer
together and shifted towards higher intensities compared to control subjects.
doi:10.1371/journal.pone.0062927.g006
Table 2. Statistical analyses of sloped, sloper, i50d, i50r, and the difference between i50d and i50r (i50r–i50d) between control
subjects, CSNB2, and CSNB1 patients.
sloped sloper i50d i50r i50r–i50d
overall effect F(2,38) =127.7 ** F(2,38) =20.1** F(2,38) =79.4** F(2,38) =39.8** F(2,38) =26.9**
control subjects - CSNB2 * n.s. ** ** n.s.
control subjects - CSNB1 ** ** ** ** **
CSNB2 - CSNB1 ** ** ** n.s. **
Analyses were performed through One-Way ANOVA tests (overall effect) and Bonferroni corrected Post Hoc tests for pairwise multiple comparisons.
**p-value ,0.001.
*p-value ,0.05.
n.s. not significantly different.
doi:10.1371/journal.pone.0062927.t002
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of normal subjects. However, their final thresholds were 0.4 to 1.9
log units elevated. Their scotopic visual field showed a slightly
decreasing threshold from mid to end, just as in control subjects,
but with an elevated absolute threshold. The 2D Light Lab results
of CSNB2 patients and control subjects showed a comparable
number of intensity steps to detect and recognize all objects (small
difference in sloped and sloper). However, the intensity at which
50% of the objects were detected and recognized (i50d and i50r)
were higher in patients and varied over a range of over 2 log units.
The minimal night vision problems reported by all CSNB2
patients may therefore be explained by their relatively intact visual
fields, and the similarity of the DA curves and 2D Light Lab results
compared to control subjects. The increase in thresholds means
that only in very dark conditions (i.e. starlight) difficulties may be
expected.
We also compared the results of three pairs of CSNB2 brothers.
Their differences in scotopic tests results were comparable to those
of unrelated CSNB2 patients. The brothers also mentioned
differences in their experience of visual problems in the dark.
This indicates that other genetic, environmental factors [13,21] or
personal factors may be more important in determining the
severity of night vision problems in CSNB2 than different
mutations in the causative disease gene.
The results of the questionnaire showed that CSNB1 patients
varied in their experience of difficult situations. They also
answered variably on the questions how often they felt blind at
night (Q27) and restricted because of their vision at night (Q29).
The variation among CSNB1 patients may partially be explained
by variation in visual acuity. Overall, all CSNB1 patients
experienced night vision problems, but we would not describe
them as severe.
Despite the variable answers on the questionnaire, the scotopic
test results in CSNB1 patients were very similar. The first part of
the DA curve differed between subjects, but the final elevated
thresholds lay close together, between 2.85 and 3.1 log units. This
has been described before, without an explanation [2]. Also, their
scotopic visual fields were very similar as were the results from the
2D light lab. Because the CSNB1 patients had different mutations,
genotype appears not to be related to scotopic functioning.
The scotopic field of the CSNB1 patients showed a minimal
decline of the thresholds from the middle towards 75u, comparable
to the decline found in control subjects. This means that the visual
fields in CSNB1 patients were relatively intact, albeit with
increased thresholds. In the 2D Light Lab, CSNB1 patients were
completely blind at the lowest light levels (starlight). However,
above a certain light level, they went from seeing nothing to seeing
almost everything in one or two 0.5 log intensity steps. The light
level at which the CSNB1 patients recognized and detected half of
the objects corresponds to full moonlight illuminance. The light
level at which all objects were recognized and detected
approached that of the control subjects. Our results from the
scotopic visual fields and the 2D light lab may explain the limited
night vision problems in CSNB1. CSNB1 patients are blind by
starlight, but when the light level exceeds a certain minimum, their
visual field is normal and they can detect and recognize all objects
equally well as persons with normal vision. In the western world,
most villages, cities, streets and highways are very well illuminated
and so the light level is high enough for CSNB1 patients.
In CSNB2, the transmission of both rod and cone signals is
affected but reduced activity remains present [3]. Our study shows
that the remaining scotopic functions vary between CSNB2
patients, suggesting that the extent to which signal transmission in
CSNB2 is affected varies. This may explain the correlation
between the visual acuity and the intensity at which 50% of the
objects were detected (i50d) or recognized (i50d). Possibly, more
severely affected signal transmission results in poorer visual acuity
(cone system), and more light needed to see objects (rod system). In
CSNB1, defective ON bipolar cell function leads to absent rod
pathway signalling [4]. In our study, we found impaired but equal
scotopic functions in CSNB1 patients: DA thresholds and scotopic
visual fields all showed highly elevated thresholds. A previous study
on dark adapted perimetry concluded that the scotopic visual field
of a CSNB patient (probably CSNB1) was determined by the cone
system only [33]. Our results confirm that rod signal transmission
is completely blocked in CSNB1, with no variations in severity
among patients.
In the 2D light lab, both control subjects and CSNB2 patients
detected and recognized objects at very low intensities. This
suggests that the rod system determines their detection and
recognition curves. In contrast, the cone system most likely
determines the detection and recognition curves of the CSNB1
patients, as they detected and recognized objects at higher
intensities. However, in the CSNB1 patients we not only found
Figure 7. Linear regression between the intensity at which 50%
of the objects were detected (i50d) or recognized (i50r) and the
visual acuity. The lines resemble the simple linear regression fits. A:
The Pearson correlation coefficient for i50d and the visual acuity was
R=0.84, p,0.01 for the CSNB2 patients, and R=0.41, p.0.05 for the
CSNB1 patients. B: The Pearson correlation coefficient for i50r and the
visual acuity was R= 0.92, p,0.01 for the CSNB2 patients, and R= 0.86,
p,0.01 for the CSNB1 patients.
doi:10.1371/journal.pone.0062927.g007
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higher values for i50d and i50r, but also for sloped and sloper,
compared to the control subjects and CSNB2 patients. The
question rises why the rod system induces a relatively low sloped
and sloper compared to the cone system. Our hypothesis is that the
rod system is very sensitive at low intensities, but at the expense of
detail, while at higher intensities the rod system desensitizes but
improves in signal to noise ratio. This hypothesis explains our
observation that subjects only saw large or high contrast objects at
low intensities. Furthermore, it may also explain the 1 log unit
intensity shift between the detection curve and recognition curve
determined by the rod system: more details are needed to
recognize the object after it has been detected. In contrast, the
cone system operates only at a certain minimal intensity but always
at a high signal to noise ratio. Therefore, above the cone system
threshold all objects can be detected and recognized.
The DA curve is considered the defining psychophysical
measurement of night blindness [16]. More severe night vision
problems are expected with more elevated thresholds. However, in
our study CSNB1 patients had highly elevated DA thresholds (3
log units), but did not experience severe night vision problems, as
assessed by the questionnaire. This may be explained by their
relatively intact wide scotopic visual fields and the results of the 2D
Light Lab, showing that they immediately regained vision at
intensities just above the threshold. Thus, the combination of the
three scotopic tests explained the results from the questionnaire.
The scotopic visual field test and the 2D light lab test may be of
value in predicting night vision problems in patients. Furthermore,
the 2D light lab, as did the original 3D light lab, may be very
useful in demonstrating to both patients and relatives the
consequences of their disorder [31,34]. However, further studies
on scotopic tests in other retinal disorders are needed to confirm
their clinical use in objectively assessing night blindness.
With this study, where we used two scotopic tests and
a questionnaire in addition to the conventional DA curve, we
add to the evidence that CSNB2 patients experience none or
hardly any symptoms of night blindness. Furthermore, we showed
that CSNB1 patients do experience night vision problems, but
only in very dark circumstances (below full moonlight illumi-
nance). Therefore, in the modern western world, CSNB1 patients
need little adaptations in daily life routine. Rehabilitation centres
and parents of young patients need to know that CSNB2 patients
have no extra difficulty at night compared to day time, and that
CSNB1 patients can move around in the dark independently as
long as there is enough street lighting. Ophthalmologists need to
know, that because of almost absent symptoms of night blindness
in CSNB2 and mild symptoms in CSNB1, the name congenital
stationary night blindness may lead to misunderstanding when
explaining the condition to parents and patients. As previously
stressed by Riemslag [34], names of disorders should not refer to
(possible) reduced functions. We would recommend to change the
name CSNB into more neutral terms related to the true retinal
deficiency, for instance ‘‘ON-bipolar deficiency’’ for CSNB1 and
‘‘photoreceptor synapse deficiency’’ for CSNB2.
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